IQVIA raised its 2026 adjusted profit forecast to $12.90–$13.00 per share after stronger clinical-research demand helped third-quarter sales and earnings beat expectations.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →Financials
Technicals
Earnings-peers